Unknown

Dataset Information

0

PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants.


ABSTRACT: Morphine has large pharmacokinetic variability, which is further complicated by developmental changes in neonates and small infants. The impacts of organic cation transporter 1 (OCT1) genotype and changes in blood-flow on morphine clearance (CL) were previously demonstrated in children, whereas changes in UDP-glucuronosyltransferase 2B7 (UGT2B7) activity showed a small effect. This study, targeting neonates and small infants, was designed to assess the influence of developmental changes in OCT1 and UGT2B7 protein expression and modified blood-flow on morphine CL using physiologically based pharmacokinetic (PBPK) modeling. The implementation of these three age-dependent factors into the pediatric system platform resulted in reasonable prediction for an age-dependent increase in morphine CL in these populations. Sensitivity of morphine CL to changes in cardiac output increased with age up to 3 years, whereas sensitivity to changes in UGT2B7 activity decreased. This study suggests that morphine exhibits age-dependent extraction, likely due to the developmental increase in OCT1 and UGT2B7 protein expression/activity and hepatic blood-flow.

SUBMITTER: Emoto C 

PROVIDER: S-EPMC6063742 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants.

Emoto Chie C   Johnson Trevor N TN   Neuhoff Sibylle S   Hahn David D   Vinks Alexander A AA   Fukuda Tsuyoshi T  

CPT: pharmacometrics & systems pharmacology 20180619 7


Morphine has large pharmacokinetic variability, which is further complicated by developmental changes in neonates and small infants. The impacts of organic cation transporter 1 (OCT1) genotype and changes in blood-flow on morphine clearance (CL) were previously demonstrated in children, whereas changes in UDP-glucuronosyltransferase 2B7 (UGT2B7) activity showed a small effect. This study, targeting neonates and small infants, was designed to assess the influence of developmental changes in OCT1  ...[more]

Similar Datasets

| S-EPMC5321811 | biostudies-other
| S-EPMC6047210 | biostudies-literature
| S-EPMC7501088 | biostudies-literature
| S-EPMC4999604 | biostudies-literature
| S-EPMC4190075 | biostudies-literature
| S-EPMC4116670 | biostudies-literature
| S-EPMC7010644 | biostudies-literature
| S-EPMC4532713 | biostudies-literature
| S-EPMC5903239 | biostudies-literature
| S-EPMC5466424 | biostudies-other